PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company has, on the recommendation of Nomination and Remuneration Committee, appointed Mr. Narotam Kumar Juneja (DIN: 01204817) as an additional director (in the capacity of Non-Executive Non-Independent Director) on the Board of Directors of the Company with effect from April 01, 2022. In accordance with the circular dated June 20, 2018, issued by the Stock Exchanges, we have got the confirmation from Mr. Narotam Kumar Juneja that he is not debarred from accessing the capital market and / or restrained from holding the office of Director by virtue of any order of SEBI or any other such authority. The details as required to be disclosed under the aforesaid Regulation 30 read with Clause 7 of Para A of Annexure I of SEBI Circular dated 09 September, 2015 is enclosed as Annexure - A to this letter.01-04-2022